Why Verastem Stock Jumped Briefly This Morning

Why Verastem Stock Jumped Briefly This Morning

Shares of Verastem (NASDAQ: VSTM) jumped by as much as 11% this morning after the company reported second-quarter earnings and announced a deal to sell development rights to a drug. Verastem also said it had entered into a definitive agreement to sell its global commercial and development rights to COPIKTRA (duvelisib) to Secura Bio in a deal worth up to $311 million. "The first half of 2020 has been a time of transformational change at Verastem Oncology," CEO Brian Stuglik said in a statement.